U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Rosuvastatin Calcium (marketed as Crestor) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Rosuvastatin Calcium (marketed as Crestor) Information

Crestor is in a class of drugs called "statins." Statins are prescription drugs used together with diet and exercise to reduce blood levels of low-density lipoprotein (LDL) cholesterol ("bad cholesterol").
 

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.

Related Information

For archived content below see Rosuvastatin Calcium (marketed as Crestor) Information

  • Questions and Answers for Healthcare Professionals: CRESTOR and the JUPITER Trial
  • Information for Healthcare Professionals: Crestor (Rosuvastatin Calcium)
  • FDA Public Health Advisory for Crestor (rosuvastatin)
  • FDA Provides Updated Patient and Healthcare Provider Information Concerning Crestor
  • FDA Response to a Citizen Petition on Crestor (3/14/2005)
  • Historical Information on Crestor (rosuvastatin calcium)
  • Public Health Advisory for Crestor (rosuvastatin)

Labeling and Regulatory History from Drugs@FDA

Back to Top